アレルギー診断薬市場規模、シェア、成長分析、製品別、検査別、アレルゲン別、エンドユーザー別、地域別 - 産業予測 2025～2032年

アレルギー診断薬市場規模は2023年に48億米ドルと評価され、2024年の53億3,000万米ドルから2032年には122億8,000万米ドルに成長する見通しで、予測期間（2025-2032年）のCAGRは11.0％です。

アレルギー診断薬市場は、アレルギーの有病率の増加、診断技術の進歩、検査オプションに対する意識の高まりによって大きな成長を遂げています。花粉症、喘息、食物アレルギーなどの症状は、環境要因やライフスタイルの変化により増加しており、業界の拡大を刺激しています。皮膚プリックテストや分子診断のようなツールの革新は、検査の効率と精度を高める。しかし、市場は、規制上のハードル、先端技術の高コスト、標準化の欠如などの課題に直面しており、これらは患者の信頼性とアクセシビリティに影響を与える可能性があります。こうした障害にもかかわらず、市場は、新たな診断方法、機械学習とAIの統合、ヘルスケアインフラへの投資の増加によって、大きく成長するとみられています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制分析

アレルギー診断薬市場規模：製品別& CAGR（2025-2032）

• 市場概要
• アッセイキット
• 機器
• サービス
• 消耗品

アレルギー診断薬市場規模：検査別& CAGR（2025-2032）

• 市場概要
• 生体内試験
• 体外試験

アレルギー診断薬市場規模：アレルゲン別& CAGR（2025-2032）

• 市場概要
• 吸入アレルゲン
• 食物アレルゲン
• 薬物アレルゲン
• その他のアレルゲン

アレルギー診断薬市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 診断検査室
• 病院併設の検査室
• 学術調査機関
• その他のエンドユーザー

アレルギー診断薬市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024年）

主要企業プロファイル

• Thermo Fisher Scientific Inc.（US）
• Siemens Healthineers AG（Germany）
• Danaher（US）
• Canon Inc.（Minaris Medical America, Inc.）（Japan/US）
• Eurofins Scientific（Luxembourg）
• EUROIMMUN Medizinische Labordiagnostika AG（Revvity Inc.）（Germany/US）
• bioMerieux SA（France）
• Stallergenes Greer Ltd.（UK）
• HollisterStier Allergy（US）
• Omega Diagnostics Group PLC（UK）
• R-Biopharm AG（Germany）
• HYCOR Biomedical（US）
• Lincoln Diagnostics, Inc.（US）
• HOB Biotech Group Corp., Ltd.（China）
• Romer Labs Division Holding GmbH（Austria）
• AESKU.GROUP GmbH（Germany）
• Neogen Corporation（US）
• ALK-Abello A/S（Denmark）
• Abbott Laboratories（US）
• Phadia（part of Thermo Fisher Scientific）（Sweden/US）

結論と提言

Allergy Diagnostics Market size was valued at USD 4.8 billion in 2023 and is poised to grow from USD 5.33 billion in 2024 to USD 12.28 billion by 2032, growing at a CAGR of 11.0% during the forecast period (2025-2032).

The allergy diagnostics market is experiencing significant growth, driven by an increasing prevalence of allergies, advancements in diagnostic technologies, and heightened awareness of testing options. Conditions such as hay fever, asthma, and food allergies are rising due to environmental factors and lifestyle changes, stimulating the industry's expansion. Innovations in tools like skin prick tests and molecular diagnostics enhance testing efficiency and accuracy. However, the market faces challenges, including regulatory hurdles, high costs of advanced technologies, and a lack of standardization, which can impact reliability and accessibility for patients. Despite these obstacles, the market is set to grow substantially, fueled by emerging diagnostic methods, the integration of machine learning and AI, and increased investments in healthcare infrastructure.

Top-down and bottom-up approaches were used to estimate and validate the size of the Allergy Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Allergy Diagnostics Market Segments Analysis

Global Allergy Diagnostics Market is segmented by Product, Tests, Allergen, End User and region. Based on Product, the market is segmented into Assay Kits, Instruments, Services and Consumables. Based on Tests, the market is segmented into In-vivo Tests and In-vitro Tests. Based on Allergen, the market is segmented into Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens. Based on End User, the market is segmented into Diagnostic Laboratories, Hospital-Based Laboratories, Academic Research Institutes and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Allergy Diagnostics Market

The rising trend of personalized medicine is significantly influencing the allergy diagnostics market. There is a growing demand for allergy testing that provides detailed insights into individual sensitivities, facilitating more tailored treatment options. Ongoing research focused on identifying specific biomarkers linked to allergies enhances the ability to develop customized therapeutic strategies. This shift towards personalized approaches not only improves patient care but also contributes to the expansion of the allergy diagnostics industry, as healthcare providers seek tools that enable them to deliver more targeted and effective treatments based on individual patient profiles.

Restraints in the Allergy Diagnostics Market

The proliferation of home testing kits and DIY methods is posing a significant challenge to the growth of the allergy diagnostics market. While these home-based allergy tests provide convenience for patients, they often lack the accuracy and reliability of laboratory diagnostics. This shift in preference may lead to a decline in demand for professional testing services, adversely impacting market expansion. Additionally, the adoption of DIY methods and home remedies could further stagnate the allergy diagnostics industry as patients opt for less reliable alternatives over professional consultation and testing, ultimately undermining the effectiveness and revenue potential of established diagnostic facilities.

Market Trends of the Allergy Diagnostics Market

The Allergy Diagnostics market is witnessing a significant trend towards the adoption of molecular diagnostic techniques, such as allergen component testing and next-generation sequencing. These advanced methodologies facilitate precise identification of allergens at a molecular level, leading to more accurate diagnostics and the development of tailored treatment plans that cater to individual patient sensitivities. As a result, healthcare providers can deliver enhanced patient outcomes, fostering a shift towards personalized medicine in allergy management. The use of established molecular methods, including ELISA, PCR, and NHS, is expected to surge, further propelling market growth and innovation in allergy diagnostics.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis

Global Allergy Diagnostics Market Size by Product & Services & CAGR (2025-2032)

• Market Overview
• Assay Kits
• Instruments
• Services
• Consumables

Global Allergy Diagnostics Market Size by Tests & CAGR (2025-2032)

• Market Overview
• In-vivo Tests
• In-vitro Tests

Global Allergy Diagnostics Market Size by Allergen & CAGR (2025-2032)

• Market Overview
• Inhaled Allergens
• Food Allergens
• Drug Allergens
• Other Allergens

Global Allergy Diagnostics Market Size by End User & CAGR (2025-2032)

• Market Overview
• Diagnostic Laboratories
• Hospital-Based Laboratories
• Academic Research Institutes
• Other End Users

Global Allergy Diagnostics Market Size & CAGR (2025-2032)

• North America (Product & Services, Tests, Allergen, End User)
  • US
  • Canada
• Europe (Product & Services, Tests, Allergen, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Services, Tests, Allergen, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Services, Tests, Allergen, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Services, Tests, Allergen, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Inc. (Minaris Medical America, Inc.) (Japan/US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EUROIMMUN Medizinische Labordiagnostika AG (Revvity Inc.) (Germany/US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stallergenes Greer Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HollisterStier Allergy (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omega Diagnostics Group PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• R-Biopharm AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HYCOR Biomedical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lincoln Diagnostics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HOB Biotech Group Corp., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Romer Labs Division Holding GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AESKU.GROUP GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ALK-Abello A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phadia (part of Thermo Fisher Scientific) (Sweden/US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations